Table 9 Projected health impact of the GPELF (2000–2014) over lifetime of the benefit cohorts
Benefit cohort | Number of chronic cases averted (millions) | Years of chronic disease averted (millions) | Number of acute (ADL) episodes averted (millions) | DALYs averted (millions)a |
|---|---|---|---|---|
1. Protected from acquiring infection | 21 | 938 | 2,157 | 103 (68–147) |
2. Subclinical morbidity prevented from progressing | 12 | 551 | 1,267 | 62 (41–88) |
3. Alleviated clinical disease | 3 | 104 | 1,264 | 11 (8–16) |
Total | 36 | 1,592 | 4,689 | 175 (116–250) |